Acute vision loss (noninflamed): Difference between revisions

No edit summary
(Add peer-reviewed references with PMIDs)
 
(20 intermediate revisions by 6 users not shown)
Line 1: Line 1:
==Diagnosis ==
==Background==
#Retinal detachment^
[[File:Schematic diagram of the human eye en.png|thumb|Eye anatomy.]]
#Central retinal art occlusion^
*This page describes a general approach to the complaint of acute vision loss with a quiet (noninflamed) eye
#Central retinal vein occlusion^
*Acute painless vision loss is an ophthalmologic emergency — several causes are time-sensitive
#Arteritic anterior ischemic optic neuropathy
*Central retinal artery occlusion (CRAO) is a stroke equivalent with a narrow treatment window (<ref>Hayreh SS. Acute retinal arterial occlusive disorders. Prog Retin Eye Res. 2011;30(5):359-394. PMID 21620994</ref><4.5-6 hours)
#Vitreous hemorrhage
*Key distinguishing feature: painless vision loss in a quiet eye narrows the differential to primarily vascular and retinal etiologies
#High-altitude retinal hemorrhage
*Always check visual acuity in both eyes as a baseline
#Temporal arteritis^


^ Emergent Diagnosis
==Clinical Features==
===Key Historical Features===
*Monocular vs. binocular vision loss (binocular suggests central/neurologic cause)
*Onset: sudden (vascular) vs. gradual (optic neuritis, detachment progression)
*Transient vs. persistent: amaurosis fugax (transient monocular vision loss) suggests TIA/carotid disease
*Visual field deficit pattern: central (macular), peripheral (retinal detachment), altitudinal (branch artery/vein occlusion)
*Associated symptoms: headache, jaw claudication, scalp tenderness (giant cell arteritis), floaters/flashes (retinal detachment)<ref>Hunder GG, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33(8):1122-1128. PMID 2202311</ref>
*Pain with eye movement (optic neuritis)


^^ Critiacal Diagnosis
===Physical Exam===
*Visual acuity (each eye independently) — document with Snellen chart or near card
*Pupillary exam: relative afferent pupillary defect (RAPD/Marcus Gunn pupil) present in optic nerve or extensive retinal pathology
*Visual field testing by confrontation
*Extraocular movements
*Fundoscopy: look for pale retina with cherry red spot (CRAO), papilledema, retinal hemorrhages, retinal detachment


==Source==
==Differential Diagnosis==
3/20/06 DONALDSON (adapted from Rosen, WMS Practice Guidelines 2000)
{{Acute vision loss noninflamed DDX}}


[[Category:Ophtho]]
===Vascular===
*[[Central retinal artery occlusion]] (CRAO): painless sudden monocular vision loss, pale retina with cherry-red spot
*[[Central retinal vein occlusion]] (CRVO): painless monocular vision loss, "blood and thunder" fundus
*[[Amaurosis fugax]]: transient monocular vision loss, carotid embolic source
*[[Giant cell arteritis]] (GCA/temporal arteritis): vision loss (may be bilateral), headache, jaw claudication, elevated ESR/CRP
*Ischemic optic neuropathy (anterior or posterior)
 
===Retinal===
*[[Retinal detachment]]: flashes, floaters, "curtain" over visual field, pigmented cells in vitreous
*[[Vitreous hemorrhage]]: sudden painless vision loss, absent red reflex, history of diabetes/trauma
 
===Neurologic===
*[[Optic neuritis]]: painful eye movements, central vision loss, RAPD, associated with MS
*Stroke affecting visual cortex: binocular homonymous hemianopsia
*Papilledema from elevated [[ICP]]: bilateral vision changes, headache
*Pituitary apoplexy: bitemporal hemianopsia, headache
 
==Evaluation==
===Bedside===
*Visual acuity (each eye separately)
*Pupillary exam for RAPD
*Confrontation visual fields
*Fundoscopy (dilated if safe — avoid dilation if concern for neurologic cause requiring pupil monitoring)
*[[POCUS]]: ocular ultrasound can identify retinal detachment, vitreous hemorrhage, increased optic nerve sheath diameter (elevated ICP)
*Intraocular pressure (IOP) — elevated in acute angle closure (though this is typically painful/inflamed)
 
===Laboratory===
*'''ESR and CRP''' (STAT) if giant cell arteritis suspected — do not delay treatment
*[[CBC]], [[BMP]]
*[[Glucose]] (diabetic retinopathy)
*Consider hypercoagulability workup for retinal vascular occlusion in young patients
 
===Imaging===
*CT/CTA head if stroke suspected
*MRI brain/orbits with gadolinium for optic neuritis
*Carotid duplex ultrasound or CTA neck for amaurosis fugax / CRAO (embolic source evaluation)
 
==Management==
===Time-Sensitive Emergencies===
*'''CRAO''': true ophthalmologic emergency (treatment window <4.5-6 hours)
**Emergent ophthalmology consultation
**Consider ocular massage, anterior chamber paracentesis (ophthalmology)
**Intra-arterial tPA may be considered at specialized centers
**Evaluate for embolic source (carotid, cardiac)
*'''Giant cell arteritis''': start high-dose IV [[methylprednisolone]] (1g/day) immediately if clinical suspicion high — do NOT wait for biopsy results
**Temporal artery biopsy within 1-2 weeks (steroids do not affect biopsy for several days)
*Retinal detachment: emergent ophthalmology consultation for surgical repair
**Macula-on detachments are more urgent (better visual outcomes with earlier repair)
*Optic neuritis: neurology and ophthalmology consultation; high-dose IV corticosteroids may hasten recovery
 
===Non-Emergent===
*CRVO: ophthalmology follow-up within 24-48 hours
*Vitreous hemorrhage: ophthalmology referral, head-of-bed elevation
*Amaurosis fugax: stroke workup (treat as TIA equivalent)
 
==Disposition==
===Emergent Ophthalmology Consultation===
*CRAO (within treatment window)
*Retinal detachment (especially macula-on)
*Giant cell arteritis with vision loss
 
===Admit===
*Giant cell arteritis (for IV steroids and monitoring)
*CRAO with concern for concurrent stroke
*Amaurosis fugax/TIA (per stroke protocol)
*Bilateral vision loss from neurologic cause
 
===Discharge with Urgent Follow-Up===
*CRVO: ophthalmology within 24-48 hours
*Vitreous hemorrhage (nontraumatic): ophthalmology within 24 hours
*Optic neuritis: neurology and ophthalmology within days
*Return precautions: worsening vision loss, new symptoms in other eye, headache, weakness
 
==See Also==
{{Eye algorithms}}
*[[Retinal detachment]]
*[[Central retinal artery occlusion]]
*[[Giant cell arteritis]]
*[[Amaurosis fugax]]
 
==External Links==
 
==References==
<References/>
 
[[Category:Ophthalmology]]
[[Category:Symptoms]]

Latest revision as of 09:57, 22 March 2026

Background

Eye anatomy.
  • This page describes a general approach to the complaint of acute vision loss with a quiet (noninflamed) eye
  • Acute painless vision loss is an ophthalmologic emergency — several causes are time-sensitive
  • Central retinal artery occlusion (CRAO) is a stroke equivalent with a narrow treatment window ([1]<4.5-6 hours)
  • Key distinguishing feature: painless vision loss in a quiet eye narrows the differential to primarily vascular and retinal etiologies
  • Always check visual acuity in both eyes as a baseline

Clinical Features

Key Historical Features

  • Monocular vs. binocular vision loss (binocular suggests central/neurologic cause)
  • Onset: sudden (vascular) vs. gradual (optic neuritis, detachment progression)
  • Transient vs. persistent: amaurosis fugax (transient monocular vision loss) suggests TIA/carotid disease
  • Visual field deficit pattern: central (macular), peripheral (retinal detachment), altitudinal (branch artery/vein occlusion)
  • Associated symptoms: headache, jaw claudication, scalp tenderness (giant cell arteritis), floaters/flashes (retinal detachment)[2]
  • Pain with eye movement (optic neuritis)

Physical Exam

  • Visual acuity (each eye independently) — document with Snellen chart or near card
  • Pupillary exam: relative afferent pupillary defect (RAPD/Marcus Gunn pupil) present in optic nerve or extensive retinal pathology
  • Visual field testing by confrontation
  • Extraocular movements
  • Fundoscopy: look for pale retina with cherry red spot (CRAO), papilledema, retinal hemorrhages, retinal detachment

Differential Diagnosis

Acute Vision Loss (Noninflamed)

Emergent Diagnosis

Vascular

Retinal

  • Retinal detachment: flashes, floaters, "curtain" over visual field, pigmented cells in vitreous
  • Vitreous hemorrhage: sudden painless vision loss, absent red reflex, history of diabetes/trauma

Neurologic

  • Optic neuritis: painful eye movements, central vision loss, RAPD, associated with MS
  • Stroke affecting visual cortex: binocular homonymous hemianopsia
  • Papilledema from elevated ICP: bilateral vision changes, headache
  • Pituitary apoplexy: bitemporal hemianopsia, headache

Evaluation

Bedside

  • Visual acuity (each eye separately)
  • Pupillary exam for RAPD
  • Confrontation visual fields
  • Fundoscopy (dilated if safe — avoid dilation if concern for neurologic cause requiring pupil monitoring)
  • POCUS: ocular ultrasound can identify retinal detachment, vitreous hemorrhage, increased optic nerve sheath diameter (elevated ICP)
  • Intraocular pressure (IOP) — elevated in acute angle closure (though this is typically painful/inflamed)

Laboratory

  • ESR and CRP (STAT) if giant cell arteritis suspected — do not delay treatment
  • CBC, BMP
  • Glucose (diabetic retinopathy)
  • Consider hypercoagulability workup for retinal vascular occlusion in young patients

Imaging

  • CT/CTA head if stroke suspected
  • MRI brain/orbits with gadolinium for optic neuritis
  • Carotid duplex ultrasound or CTA neck for amaurosis fugax / CRAO (embolic source evaluation)

Management

Time-Sensitive Emergencies

  • CRAO: true ophthalmologic emergency (treatment window <4.5-6 hours)
    • Emergent ophthalmology consultation
    • Consider ocular massage, anterior chamber paracentesis (ophthalmology)
    • Intra-arterial tPA may be considered at specialized centers
    • Evaluate for embolic source (carotid, cardiac)
  • Giant cell arteritis: start high-dose IV methylprednisolone (1g/day) immediately if clinical suspicion high — do NOT wait for biopsy results
    • Temporal artery biopsy within 1-2 weeks (steroids do not affect biopsy for several days)
  • Retinal detachment: emergent ophthalmology consultation for surgical repair
    • Macula-on detachments are more urgent (better visual outcomes with earlier repair)
  • Optic neuritis: neurology and ophthalmology consultation; high-dose IV corticosteroids may hasten recovery

Non-Emergent

  • CRVO: ophthalmology follow-up within 24-48 hours
  • Vitreous hemorrhage: ophthalmology referral, head-of-bed elevation
  • Amaurosis fugax: stroke workup (treat as TIA equivalent)

Disposition

Emergent Ophthalmology Consultation

  • CRAO (within treatment window)
  • Retinal detachment (especially macula-on)
  • Giant cell arteritis with vision loss

Admit

  • Giant cell arteritis (for IV steroids and monitoring)
  • CRAO with concern for concurrent stroke
  • Amaurosis fugax/TIA (per stroke protocol)
  • Bilateral vision loss from neurologic cause

Discharge with Urgent Follow-Up

  • CRVO: ophthalmology within 24-48 hours
  • Vitreous hemorrhage (nontraumatic): ophthalmology within 24 hours
  • Optic neuritis: neurology and ophthalmology within days
  • Return precautions: worsening vision loss, new symptoms in other eye, headache, weakness

See Also

Eye Algorithms

External Links

References

  1. Hayreh SS. Acute retinal arterial occlusive disorders. Prog Retin Eye Res. 2011;30(5):359-394. PMID 21620994
  2. Hunder GG, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33(8):1122-1128. PMID 2202311